|
1
|
Marmol I, Sanchez-de-Diego C, Pradilla DA,
Cerrada E and Rodriguez YM: Colorectal carcinoma: A general
overview and future perspectives in colorectal cancer. Int J Mol
Sci. 18:E1972017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papanastasopoulos P and Stebbing J:
Molecular basis of 5-fluorouracil-related toxicity: Lessons from
clinical practice. Anticancer Res. 34:1531–1535. 2014.PubMed/NCBI
|
|
4
|
Bharti AC and Aggarwal BB: Nuclear
factor-kappa B and cancer: Its role in prevention and therapy.
Biochem Pharmacol. 64:883–888. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang J, Chen Y, Li J, Zhang K, Chen J,
Chen D, Feng B, Song H, Feng J, Wang R and Chen L: Notch-1 confers
chemoresistance in lung adenocarcinoma to Taxanes through
AP-1/microRNA-451 mediated regulation of MDR-1. Mol Ther Nucleic
Acids. 5:e3752016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie Y and Zhong DW: AEG-1 is associated
with hypoxia-induced hepatocellular carcinoma chemoresistance via
regulating PI3K/AKT/HIF-1alpha/MDR-1 pathway. EXCLI J. 15:745–757.
2016.PubMed/NCBI
|
|
7
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Magee JA, Piskounova E and Morrison SJ:
Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer
Cell. 21:283–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vander Griend DJ, Karthaus WL, Dalrymple
S, Meeker A, DeMarzo AM and Isaacs JT: The role of CD133 in normal
human prostate stem cells and malignant cancer-initiating cells.
Cancer Res. 68:9703–9711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seymour T, Nowak A and Kakulas F:
Targeting aggressive cancer stem cells in glioblastoma. Front
Oncol. 5:1592015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Watanabe Y, Yoshimura K, Yoshikawa K,
Tsunedomi R, Shindo Y, Matsukuma S, Maeda N, Kanekiyo S, Suzuki N,
Kuramasu A, et al: A stem cell medium containing neural stimulating
factor induces a pancreatic cancer stem-like cell-enriched
population. Int J Oncol. 45:1857–1866. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsukuma S, Yoshimura K, Ueno T, Oga A,
Inoue M, Watanabe Y, Kuramasu A, Fuse M, Tsunedomi R, Nagaoka S, et
al: Calreticulin is highly expressed in pancreatic cancer stem-like
cells. Cancer Sci. 107:1599–1609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hashimoto N, Tsunedomi R, Yoshimura K,
Watanabe Y, Hazama S and Oka M: Cancer stem-like sphere cells
induced from de-differentiated hepatocellular carcinoma-derived
cell lines possess the resistance to anti-cancer drugs. BMC Cancer.
14:7222014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang F, Ma L, Zhang Z, Liu X, Gao H,
Zhuang Y, Yang P, Kornmann M, Tian X and Yang Y: Hedgehog signaling
regulates epithelial-mesenchymal transition in pancreatic cancer
stem-like cells. J Cancer. 7:408–417. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakamura Y, Takahashi N, Kakegawa E,
Yoshida K, Ito Y, Kayano H, Niitsu N, Jinnai I and Bessho M: The
GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a
result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer
Genet Cytogenet. 182:144–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ye K, Wang S, Zhang H, Han H, Ma B and Nan
W: Long noncoding RNA GAS5 suppresses cell growth and
epithelial-mesenchymal transition in osteosarcoma by regulating the
miR-221/ARHI pathway. J Cell Biochem. 118:4772–4781. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wen Q, Liu Y, Lyu H, Xu X, Wu Q, Liu N,
Yin Q, Li J and Sheng X: Long Noncoding RNA GAS5, which acts as a
tumor suppressor via microRNA 21, regulates cisplatin resistance
expression in cervical cancer. Int J Gynecol Cancer. 27:1096–1108.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu B, Wu S, Ma J, Yan S, Xiao Z, Wan L,
Zhang F, Shang M and Mao A: lncRNA GAS5 reverses EMT and tumor stem
cell-mediated gemcitabine resistance and metastasis by targeting
miR-221/SOCS3 in pancreatic cancer. Mol Ther Nucleic Acids.
13:472–482. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong X, Kong C, Liu X, Bi J, Li Z, Li Z,
Zhu Y and Zhang Z: GAS5 functions as a ceRNA to regulate hZIP1
expression by sponging miR-223 in clear cell renal cell carcinoma.
Am J Cancer Res. 8:1414–1426. 2018.PubMed/NCBI
|
|
24
|
Zhao J, Fu Y, Wu J, Li J, Huang G and Qin
L: The diverse mechanisms of miRNAs and lncRNAs in the maintenance
of liver cancer stem cells. Biomed Res Int. 2018:86860272018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Dong P, Wang W, Huang M and Tian
B: Gemcitabine treatment causes resistance and malignancy of
pancreatic cancer stem-like cells via induction of lncRNA HOTAIR.
Exp Ther Med. 14:4773–4780. 2017.PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Noh KH, Kim BW, Song KH, Cho H, Lee YH,
Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY, et al: Nanog
signaling in cancer promotes stem-like phenotype and immune
evasion. J Clin Invest. 122:4077–4093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gkountela S and Aceto N: Stem-like
features of cancer cells on their way to metastasis. Biol Direct.
11:332016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Singh S, Trevino J, Bora-Singhal N,
Coppola D, Haura E, Altiok S and Chellappan SP: EGFR/Src/Akt
signaling modulates Sox2 expression and self-renewal of stem-like
side-population cells in non-small cell lung cancer. Mol Cancer.
11:732012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu C, Zhang Y, Wang Q, Xu Z, Jiang J, Gao
Y, Gao M, Kang J, Wu M, Xiong J, et al: Long non-coding RNA GAS5
controls human embryonic stem cell self-renewal by maintaining
NODAL signalling. Nat Commun. 7:132872016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Long X, Song K, Hu H, Tian Q, Wang W, Dong
Q, Yin X and Di W: Long non-coding RNA GAS5 inhibits DDP-resistance
and tumor progression of epithelial ovarian cancer via
GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res. 38:3452019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu LL, Chen XH, Zhang G, Liu ZC, Wu N,
Wang H, Qi YF, Wang HS, Cai SH and Du J: CCL21 facilitates
chemoresistance and cancer stem cell-like Properties of colorectal
cancer cells through AKT/GSK-3β/Snail signals. Oxid Med Cell
Longev. 2016:58741272016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cioffi M, Trabulo SM, Sanchez-Ripoll Y,
Miranda-Lorenzo I, Lonardo E, Dorado J, Reis Vieira C, Ramirez JC,
Hidalgo M, Aicher A, et al: The miR-17-92 cluster counteracts
quiescence and chemoresistance in a distinct subpopulation of
pancreatic cancer stem cells. Gut. 64:1936–1948. 2015. View Article : Google Scholar : PubMed/NCBI
|
